Qlaris Bio

Dedham, MA · Founded 2019 · Privately Held (backing)

Developer of novel therapies designed to treat serious and debilitating ophthalmic diseases. Qlaris Bio is based in Dedham, MA and was founded in 2019. Its last reported valuation was $68 million in Apr 2024. It has raised $55 million across 4 recorded rounds; the latest was a $3.9 million seed round in Jun 2026.

Last reported valuation
$68.0M
Oct 2026
Priced at
—
Total raised
$55.0M
Last round
Seed Round
Jun 2026
How much has Qlaris Bio raised?
$55.0Macross 4 recorded rounds · Aug 2019 – Jun 2026

Most recently, Qlaris Bio raised $3.9M in its Seed Round (Jun 2026).

Free account
More of Qlaris Bio with a free account
  • ·Watch Qlaris Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Qlaris Bio round by round

4 rounds
Jun 2026Seed Round$3.9MSEC filing▮
8 investors participated
Nov 2025Early Stage VC$5.6MSEC filing▮
8 investors participated
Apr 2024Early Stage VC$24.0MSEC filing▮
8 investors participated
Aug 2019Early Stage VC$8.2MSEC filing▮
6 investors participated

How much has Qlaris Bio raised?

Qlaris Bio has raised $55 million across 4 recorded rounds since 2019. The largest was an $8.2 million early-stage round in Aug 2019; the most recent was a $3.9 million seed round in Jun 2026.

Qlaris Bio has filed 3 Form Ds with the SEC since 2019, most recently in Nov 2025 ($5.6 million sold to 8 investors).

Qlaris Bio investors

6 investors are on record for Qlaris Bio, including Correlation Ventures, Canaan Partners, Mayo Clinic and Mayo Clinic Ventures. The seed round in Jun 2026 drew 8 investors.

For fundraisers
Raising for a company like Qlaris Bio?

6 investors have backed Qlaris Bio.

See all 6 investors →

Frequently asked about Qlaris Bio

How much has Qlaris Bio raised?
Qlaris Bio has raised $55.0M in total across 4 recorded funding rounds.
When was Qlaris Bio's last funding round?
Qlaris Bio's most recent recorded round was Seed Round in Jun 2026, raising $3.9M.